A study to monitor the safety profile of statins in participants
Not Applicable
- Conditions
- Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
- Registration Number
- CTRI/2024/06/069448
- Lead Sponsor
- Dr Yash Goel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients (aged 18 years or older) of any gender or ethnicity.
Patients requiring statin therapy.
Patients who are willing and able to provide informed consent.
Exclusion Criteria
Patients with severe liver or kidney dysfunction
Patients with uncontrolled malignancy or other life-threatening conditions.
Pregnant or breastfeeding women.
Patients with uncontrolled endocrine disorders
Patients with cognitive impairment or psychiatric disorders that may interfere with their ability to provide informed consent or comply with the study protocol.
patients who are unwilling to give consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Study the safety profile of statin therapy at a tertiary care centre <br/ ><br>Timepoint: To Study the safety profile of statin therapy at a tertiary care centre at every 4 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method To evaluate the adverse effects associated with the use of statins. <br/ ><br>Timepoint: To evaluate the adverse effects associated with the use of statins at every 4 weeks <br/ ><br> <br/ ><br>